-transparent.png){kind=logo}
CD5-expressing B lymphocytes in the blood and salivary glands of patients with primary Sjögren's syndrome. 1988
P Youinou, and
L Mackenzie, and
G le Masson, and
N M Papadopoulos, and
J Jouquan, and
Y L Pennec, and
P Angelidis, and
P Katsikis, and
H M Moutsopoulos, and
P M Lydyard
Department of Immunology, Brest University Medical School, France.
CD5, the human counterpart of Ly-1 molecules in the mouse, are detectable but weakly expressed on a minute fraction of circulating B cells. The number of CD5 + B cells in the blood of patients with Sjögren's syndrome was slightly higher than in control blood, but it became statistically significant after treatment of the cells with phorbol myristic acetate. These numbers were even higher in patients with homogeneous serum bands than in the others. A few scattered cells were stained with anti-human IgM antibody on salivary gland sections, and among them 5-10% were found to be positive for anti-CD5.
Related Publications
P Youinou, and
L Mackenzie, and
G le Masson, and
N M Papadopoulos, and
J Jouquan, and
Y L Pennec, and
P Angelidis, and
P Katsikis, and
H M Moutsopoulos, and
P M Lydyard
March 1990,
Arthritis and rheumatism,
P Youinou, and
L Mackenzie, and
G le Masson, and
N M Papadopoulos, and
J Jouquan, and
Y L Pennec, and
P Angelidis, and
P Katsikis, and
H M Moutsopoulos, and
P M Lydyard
January 1990,
Allergologia et immunopathologia,
P Youinou, and
L Mackenzie, and
G le Masson, and
N M Papadopoulos, and
J Jouquan, and
Y L Pennec, and
P Angelidis, and
P Katsikis, and
H M Moutsopoulos, and
P M Lydyard
January 1986,
Scandinavian journal of rheumatology. Supplement,
P Youinou, and
L Mackenzie, and
G le Masson, and
N M Papadopoulos, and
J Jouquan, and
Y L Pennec, and
P Angelidis, and
P Katsikis, and
H M Moutsopoulos, and
P M Lydyard
January 1999,
Clinical and experimental immunology,
P Youinou, and
L Mackenzie, and
G le Masson, and
N M Papadopoulos, and
J Jouquan, and
Y L Pennec, and
P Angelidis, and
P Katsikis, and
H M Moutsopoulos, and
P M Lydyard
April 2007,
Arthritis and rheumatism,
P Youinou, and
L Mackenzie, and
G le Masson, and
N M Papadopoulos, and
J Jouquan, and
Y L Pennec, and
P Angelidis, and
P Katsikis, and
H M Moutsopoulos, and
P M Lydyard
July 2017,
Journal of autoimmunity,
P Youinou, and
L Mackenzie, and
G le Masson, and
N M Papadopoulos, and
J Jouquan, and
Y L Pennec, and
P Angelidis, and
P Katsikis, and
H M Moutsopoulos, and
P M Lydyard
April 1992,
The Netherlands journal of medicine,
P Youinou, and
L Mackenzie, and
G le Masson, and
N M Papadopoulos, and
J Jouquan, and
Y L Pennec, and
P Angelidis, and
P Katsikis, and
H M Moutsopoulos, and
P M Lydyard
May 2007,
Arthritis and rheumatism,
P Youinou, and
L Mackenzie, and
G le Masson, and
N M Papadopoulos, and
J Jouquan, and
Y L Pennec, and
P Angelidis, and
P Katsikis, and
H M Moutsopoulos, and
P M Lydyard
May 1988,
Arthritis and rheumatism,
P Youinou, and
L Mackenzie, and
G le Masson, and
N M Papadopoulos, and
J Jouquan, and
Y L Pennec, and
P Angelidis, and
P Katsikis, and
H M Moutsopoulos, and
P M Lydyard
January 2019,
Clinical and experimental rheumatology,
